Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Capita secures £92.4m contract extension with Southern Water

(Sharecast News) - Capita said on Thursday that it has secured a contract extension with Southern Water valued at £92.4m over five years. The extension, which was secured by the contact centre subdivision within Capita Experience, starts from July 2026. The value comprises £56.3m for the initial three years and £36.1m for the optional two-year extension.

Capita will continue to provide a comprehensive range of services to Southern Water, including front-office customer contact (voice, chat, email, social media, and complaint handling), back-office transaction processing, and early collections.

Capita Intelligent Communications (CIC) will also continue to provide Southern Water with bill printing, mail and inbound correspondence processing. As part of the contract renewal, the service will be delivered from multiple Capita locations.

Chief executive officer Corinne Ripoche said: "We are delighted to continue our partnership with Southern Water, providing essential services and keeping them at the forefront of AI-enabled customer experience in the utilities industry.

"The introduction of AgentSuite has been an incredibly positive experience for all involved, and we are excited to have the opportunity to continue to deliver even better AI-powered outcomes for the Southern Water team and their customers."

At 0838 BST, the shares were up 6.4% at 12.40p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.